Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Morelli

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Biological Chemistry|July 4, 2014
Structure of the type IX group B Streptococcus capsular polysaccharide and its evolutionary relationship with types V and VIIFrancesco Berti, Edmondo Campisi, Chiara Toniolo, et al.
The Journal of Biological Chemistry|April 16, 2008
The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesisRamiro E Llovera, Matías de Tullio, Leonardo G Alonso, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 15, 2015
Synaptosomal bioenergetic defects are associated with cognitive impairment in a transgenic rat model of early Alzheimer's diseasePamela V Martino Adami, Celia Quijano, Natalia Magnani, et al.
International Journal of Molecular Sciences|October 21, 2020
Setup and Validation of a Reliable Docking Protocol for the Development of Neuroprotective Agents by Targeting the Sigma-1 Receptor (S1R)Giacomo Rossino, Marta Rui, Luca Pozzetti, et al.
Journal of Cell Science|September 14, 2019
Perturbed mitochondria-ER contacts in live neurons that model the amyloid pathology of Alzheimer's diseasePamela V Martino Adami, Zuzana Nichtová, David B Weaver, et al.
ACS Chemical Biology|February 27, 2018
Combined Chemical Synthesis and Tailored Enzymatic Elongation Provide Fully Synthetic and Conjugation-Ready Neisseria meningitidis Serogroup X Vaccine AntigensDavide Oldrini, Timm Fiebig, Maria Rosaria Romano, et al.
Journal of Neurochemistry|February 13, 2025
The Supramolecular Architecture of Mitochondrial Complex I in the Rat Brain Is Altered by Alzheimer's-Like Cerebral AmyloidosisGisela V Novack, Pablo Galeano, Lucas A Defelipe, et al.
ACS Chemical Biology|April 24, 2015
Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed ConjugationAlberto Nilo, Laura Morelli, Irene Passalacqua, et al.
Journal of Neuroscience Research|March 3, 2004
Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's diseaseXiongwei Zhu, Andrew McShea, Peggy L R Harris, et al.
Plos One|September 3, 2025
New insights into the molecular biology of Alzheimer's-like cerebral amyloidosis achieved through multi-omics approachesLorenzo Campanelli, Juan M Sendoya, Scott Brody, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Biological Chemistry|July 4, 2014
Structure of the type IX group B Streptococcus capsular polysaccharide and its evolutionary relationship with types V and VIIFrancesco Berti, Edmondo Campisi, Chiara Toniolo, et al.
The Journal of Biological Chemistry|April 16, 2008
The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesisRamiro E Llovera, Matías de Tullio, Leonardo G Alonso, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 15, 2015
Synaptosomal bioenergetic defects are associated with cognitive impairment in a transgenic rat model of early Alzheimer's diseasePamela V Martino Adami, Celia Quijano, Natalia Magnani, et al.
International Journal of Molecular Sciences|October 21, 2020
Setup and Validation of a Reliable Docking Protocol for the Development of Neuroprotective Agents by Targeting the Sigma-1 Receptor (S1R)Giacomo Rossino, Marta Rui, Luca Pozzetti, et al.
Journal of Cell Science|September 14, 2019
Perturbed mitochondria-ER contacts in live neurons that model the amyloid pathology of Alzheimer's diseasePamela V Martino Adami, Zuzana Nichtová, David B Weaver, et al.
ACS Chemical Biology|February 27, 2018
Combined Chemical Synthesis and Tailored Enzymatic Elongation Provide Fully Synthetic and Conjugation-Ready Neisseria meningitidis Serogroup X Vaccine AntigensDavide Oldrini, Timm Fiebig, Maria Rosaria Romano, et al.
Journal of Neurochemistry|February 13, 2025
The Supramolecular Architecture of Mitochondrial Complex I in the Rat Brain Is Altered by Alzheimer's-Like Cerebral AmyloidosisGisela V Novack, Pablo Galeano, Lucas A Defelipe, et al.
ACS Chemical Biology|April 24, 2015
Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed ConjugationAlberto Nilo, Laura Morelli, Irene Passalacqua, et al.
Journal of Neuroscience Research|March 3, 2004
Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's diseaseXiongwei Zhu, Andrew McShea, Peggy L R Harris, et al.
Plos One|September 3, 2025
New insights into the molecular biology of Alzheimer's-like cerebral amyloidosis achieved through multi-omics approachesLorenzo Campanelli, Juan M Sendoya, Scott Brody, et al.
Pageof 9